Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke

American Journal of Neuroradiology

Volumn 27, Issue 4, 2006, Pages 769-773

  Sugg, Rebecca M ^a,c   Noser, E A ^a   Shaltoni, H M ^a   Gonzales, N R ^a   Campbell, M S ^b   Weir, R ^a   Cacayorin, E D ^a   Grotta, J C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Alabama Neurological Institute   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; RETEPLASE; UROKINASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BASILAR ARTERY; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; IMAGE ANALYSIS; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; RECANALIZATION; RETROSPECTIVE STUDY; SYMPTOM; UNITED STATES; ACUTE DISEASE; BRAIN ISCHEMIA; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 33748062684     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-87
2. Hacke W, Brott T, Caplan L, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 1999;53(suppl 4):s3-s14
3. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51
4. Labiche LA, Al-Senani F, Wojner AW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003;34:695-98
5. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3-13
6. Alexandrov AV, Demchuk A, Felberg R, et al. High rate of complete recanalization and dramatic clinical recovery during rPA infusion when continuously monitored with 2-mHz transcranial Doppler monitoring. Stroke 2000;31:610-14
7. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-78
8. Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-40
9. Von Krummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646-52
10. Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: correlations of outcome with clinical and radiological data. Stroke 1996;27:882-90
11. Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11
12. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial pro-urokinase foracute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-11
13. Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109-e111
14. Quereshi AI, Ali Z, Suri MR, et al. Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41-48
15. Quereshi AI, Ringer AJ, Suri MF, et al. Acute intervention for ischemic stroke: Present status and future directions. J Endovasc Ther 2000;7:423-28
16. Higashida RT, Furlan AJ, Roberts H, et al. Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-e137
17. The IMS Study Investigators. Combined intravenous and intra-arterial decimalization for acute ischemic stroke: the interventional management of Stroke Study. Stroke 2004;35:904-912
18. Noser EA, Shaltoni HM, Hall CE, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292-96
19. Zadiat O, Suarez J, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821-27
20. Keris V, Rudnicka S, Vorona V, et al. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR AM J Neuroradiol 2001;22:352-58
21. Ringer AJ, Quereshi AI, Fessier RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282-90
22. Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470-75
23. Smalling RW, Bode C, Kalbfleisch J, et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acutemyocardial infarction. Circulation 1995;91:2725-32
24. INJECT Study Group. Randomized, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;349-36
25. Noble S, McTavish D. Reteplase: A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996;52:589-605
26. Quereshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-29
27. Urokinase Pulmonary Embolism Trial Study Group. Urokinase-streptokinase embolism trial. Circulation 1974;229:1606-13
28. Tennant SN, Dixon J, Venable TC, et al. Intracoronary thrombolysis in acute myocardial infarction: comparison of the efficacy of urokinase to streptokinase. Circulation 1984;69:756-60
29. Ionue T, Kimura K, Minematsu K, et al. A case-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis 2005;19:225-28
30. Pettersen JA, Hudon ME, Hill MD. Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches. Expert Rev Cardiovasc Ther 2004;2:285-99
31. Larrue V, Von Krummer R, Del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke. Strafe 1997;28:957-60
32. Wardlaw JM, Warlow CT. Thrombolysis in acute ischemic stroke: does it work? Stroke 1992;23:1826-39
33. Mori E, Tabuchi M, Yoshida T, et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988;19:802-12
34. Deitcher SR, Jaff MR. Pharmacologic and clinical characteristics of thrombolytic agents. Rev Cardiovasc Med 2002;3:s25-s33